UPDATE: MLV Initiates Coverage On Agios Pharmaceuticals

By: via Benzinga
MLV initiated coverage on Agios Pharmaceuticals Inc (NASDAQ: AGIO) with a Buy rating and $123 price target. Analyst Arlinda Lee ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.